Sugi Predict

Sugi Predict / Compounds / SCHEMBL341047

SCHEMBL341047

SCHEMBL341047

COCC(=O)c1cccc(OC)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CES2 O00748 1/20 0.65
▸ CES1 P23141 1/20 0.65
▸ NPC1 O15118 3/20 0.64
▸ RAB9A P51151 2/20 0.64
▸ POLB P06746 1/20 0.64
▸ BLM P54132 1/20 0.64
▸ SMN1; SMN2 Q16637 1/20 0.64
▸ PARP1 P09874 1/20 0.61
▸ ALDH1A1 P00352 3/20 0.59
▸ TDP1 Q9NUW8 2/20 0.59
▸ HTT P42858 2/20 0.59
▸ LMNA P02545 2/20 0.59
▸ MAPK1 P28482 1/20 0.59
▸ L3MBTL1 Q9Y468 1/20 0.59
▸ MAPT P10636 1/20 0.59
▸ CHRM2 P08172 1/20 0.57
▸ CHRM1 P11229 1/20 0.57
▸ CHRM3 P20309 1/20 0.57
▸ HSD11B1 P28845 1/20 0.57
▸ MEN1 O00255 3/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Allylamine SCHEMBL8538509 0.88 NPC1 (0.53) CES2CES1NPC1RAB9APOLB
SCHEMBL11248287 0.85 CES2 (0.69) CES2CES1NPC1RAB9APOLB
SCHEMBL30758862 0.85 CES2 (0.69) CES2CES1NPC1RAB9APOLB
SCHEMBL7913411 0.85 SMN1; SMN2 (0.52) NPC1RAB9APOLBBLMSMN1; SMN2
SCHEMBL16937850 0.85 MEN1 (0.52) CES2CES1NPC1RAB9APOLB
SCHEMBL11755011 0.85 NPC1 (0.63) CES2CES1NPC1RAB9APOLB
SCHEMBL29207051 0.85 NPC1 (0.81) CES2CES1NPC1RAB9APOLB
SCHEMBL5696507 0.85 NPC1 (0.59) CES2CES1NPC1RAB9APOLB
SCHEMBL29207027 0.85 NPC1 (0.76) CES2CES1NPC1RAB9APOLB
SCHEMBL1305114 0.84 CES2 (0.67) CES2CES1NPC1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115745812-A Preparation method of 2-amino-1- (2,5-dimethoxyphenyl) ethanol 成都沣德煜晟医药科技有限公司 2023-03-07 — — CN claimed
CN-105755944-A Bridge construction method 张译元 2016-07-13 — — CN claimed
CN-104230755-A Chalcone derivative as well as preparation method and application thereof WUXI AIDE MEITE BIOLOG SCIENCE & TECHNOLOGY CO LTD 2014-12-24 — — CN claimed
US-8148537-B2 Substituted acetophenones useful as PDE4 inhibitors LEO PHARMA A/S (DK) 2012-04-03 — — US claimed
US-20110306775-A1 SYNTHESIS AND BIOLOGICAL EVALUATION OF 2',5'-DIMETHOXYCHALCONE DERIVATIVES AS MICROTUBULE-TARGETED ANTICANCER AGENTS KAOHSIUNG MEDICAL UNIVERSITY (TW) 2011-12-15 — — US claimed
EP-2125736-B1 SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS LEO PHARMA AS (DK) 2011-03-30 — — EP claimed
US-20100035908-A1 SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS LEO PHARMA (DK) 2010-02-11 — — US claimed
EP-2125736-A1 SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS Leo Pharma A/S (DK) 2009-12-02 — — EP claimed
CN-100434415-C Mido drine hydrochloride intermediate 2-amino-1-(2, 5-dimethoxy benzene)-alcohol preparing method TIANJIN INST PHARM RESEARCH (CN) 2008-11-19 — — CN claimed
WO-2008077404-A1 SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS LEO PHARMA A/S (DK) 2008-07-03 — — WO claimed
CN-1775739-A Mido drine hydrochloride intermediate 2-amino-1-(2, 5-dimethoxy benzene)-alcohol preparing method TIANJIN INST PHARM RESEARCH (CN) 2006-05-24 — — CN claimed
JP-63098486-A — — None — — JP disclosed
EP-3597670-B1 WATER-SOLUBLE COMPOSITION, PRODUCTION METHOD FOR CURED PRODUCT THEREOF, AND CURED PRODUCT THEREOF, AND ACYL PHOSPHINATE ADEKA CORP (JP) 2024-07-10 — — EP disclosed
US-11858930-B2 Fused bicyclic RAF inhibitors and methods for use thereof JAZZ PHARMACEUTICALS IRELAND LIMITED (IE) 2024-01-02 — — US disclosed
CN-112174800-B Preparation method of 2, 5-dimethoxy phenylacetic acid 爱斯特（成都）生物制药股份有限公司 2023-07-28 — — CN disclosed
EP-0009386-A1 2,10-Disubstituted dibenzo(b,d)pyrans and benzo(c)quinolines and pharmaceutical compositions thereof PFIZER INC. (US) 1980-04-02 — — EP disclosed
US-4182720-A Process for the preparation of homogentisic lactone IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1980-01-08 — — US disclosed
US-4017313-A Photosensitive composition containing a leuco dye, a photosensitizer, an aromatic aldehyde and a secondary or tertiary amine and the use thereof in a direct-print process E. I. DU PONT DE NEMOURS AND COMPANY (US) 1977-04-12 — — US disclosed
US-3975373-A CYCLOPENTANONE HELVETICOSIDE JOHANN A. WULFING FABRIK PHARMAZEUTISCHER PRAPARATE (DT) 1976-08-17 — — US disclosed
US-3951946-A Cardioglycoside derivatives of the strophanthidin type, a process for their manufacture and medicinal preparations containing these compounds JOHANN A. WULFING FABRIK PHARMAZEUTISCHER PRAPARATE (DT) 1976-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035908-A1 SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS PDE4A, PDE4B, PDE3B CES2 177/4885CES1 242/4885NPC1 2847/4885
US-11858930-B2 Fused bicyclic RAF inhibitors and methods for use thereof BRAF, RAF1, NRAS CES2 4215/4885CES1 2431/4885NPC1 2217/4885
US-20110306775-A1 SYNTHESIS AND BIOLOGICAL EVALUATION OF 2',5'-DIMETHOXYCHALCONE DERIVATIVES AS MICROTUBULE-TARGETED ANTICANCER AGENTS TUBB1, TUBB6, TUBA1C CES2 3831/4885CES1 3533/4885NPC1 3179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.